Position in NBIX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$10,939,594
+$2,930,454 QoQ
Shares Held
64,908
+14.9% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#150
of 768 holders
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 43%
Shared 0%
None 57%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SEGALL BRYANT & HAMILL, LLC holds $61,046,740 across 14 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (17.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
498,222 | $26,106,832 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
64,908 | $10,939,594 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
71,901 | $4,598,068 | |
| 4 | AMRX |
Amneal Pharmaceuticals, Inc.
|
240,060 | $4,155,438 | |
| 5 | LQDA |
Liquidia Corp
|
50,802 | $4,050,443 | |
| 6 | ANIP |
Ani Pharmaceuticals Inc
|
32,860 | $2,720,150 | |
| 7 | IRWD |
Ironwood Pharmaceuticals Inc
|
408,064 | $1,717,949 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
25,931 | $1,206,050 |
All Filings in NBIX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,939,594 | 64,908 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $8,009,140 | 56,470 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,647,060 | 54,474 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $5,667,487 | 45,091 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $5,873,191 | 53,103 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $6,397,755 | 46,870 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $4,202,303 | 36,472 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $5,091,587 | 36,984 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,768,881 | 20,076 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||